Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Name | RAD51C F164L |
| Gene Variant Detail | |
| Relevant Treatment Approaches |
| Molecular Profile | Indication/Tumor Type | Response Type | Relevant Treatment Approaches | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|---|
| RAD51C F164L | Advanced Solid Tumor | no benefit | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing RAD51C F164L were not sensitive to Platinol (cisplatin) in culture (PMID: 40670332). | 40670332 |